Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02745769
Title A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

mantle cell lymphoma

colorectal cancer

Therapies

Merestinib + Ramucirumab

Abemaciclib + Ramucirumab

Age Groups: adult
Covered Countries USA | FRA


No variant requirements are available.